OR WAIT null SECS
© 2022 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
May 16, 2022
May 14, 2022
May 13, 2022
May 12, 2022
May 11, 2022
Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis
An expert-led podcast with a focus on clinical trials hosted by Muthiah Vaduganathan, MD, and Stephen Greene, MD
May 10, 2022
An analysis from Northwestern Medicine provides insight into differences in cardiovascular disease mortality among subgroups of Asian Americans.
May 09, 2022
An expert in cardiovascular medicine examines current challenges associated with the treatment of atrial fibrillation.
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, discusses the clinical presentation of atrial fibrillation in patients and assesses the relationship between atrial fibrillation and syncope.
An analysis of NHANES surveys from 2001-2018 describes the overall prevalence of uncontrolled hypertension and HbA1c in adults with heart failure and provides insight into racial/ethnic disparities in prevalence.
Our latest case report features a woman in her early 60s presents to the hospital with pleuritic midsternal pain radiating from left to right and to left upper back. Check out the EKG and see if you can determine the correct diagnosis!
May 06, 2022
Investigators use data from the CDC WONDER database to assess contemporary trends in disease-specific cardiovascular causes of mortality among cancer patients in the US from 1999 to 2019.
May 05, 2022
AstraZeneca announced the phase 3 DELIVER trial has met its primary endpoint, with use of dapagliflozin associated with a statistically significant and clinically meaningful reduction in the primary composite endpoint of CV death or worsening heart failure in patients with HFmrEF and HFpEF.
An analysis of data from more than 2000 matched pairs suggests the impact of multiple risk factors, including diabetes, depression, and hypertension, on the risk of acute myocardial infarction were greater among young women than their male counterparts.
May 04, 2022
In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.
May 03, 2022
Data from the ATLAS trial suggests receiving an S-ICD was associated with a 92% lower risk of major lead-related complications compared to receiving a TV-ICD.